Genesis Healthcare Inc (NYSE:GEN) was the recipient of a large increase in short interest during the month of August. As of August 31st, there was short interest totalling 4,127,200 shares, an increase of 16.6% from the July 31st total of 3,538,300 shares. Approximately 7.9% of the shares of the stock are short sold. Based on an average daily volume of 237,500 shares, the days-to-cover ratio is presently 17.4 days.

Institutional investors and hedge funds have recently modified their holdings of the business. SG Americas Securities LLC raised its position in Genesis Healthcare by 64.0% in the 2nd quarter. SG Americas Securities LLC now owns 50,954 shares of the company’s stock valued at $63,000 after purchasing an additional 19,889 shares during the last quarter. Claraphi Advisory Network LLC acquired a new stake in shares of Genesis Healthcare in the 2nd quarter valued at $75,000. Aptus Capital Advisors LLC acquired a new stake in shares of Genesis Healthcare in the 2nd quarter valued at $145,000. Acadian Asset Management LLC increased its stake in shares of Genesis Healthcare by 16.3% in the 1st quarter. Acadian Asset Management LLC now owns 1,968,302 shares of the company’s stock valued at $2,834,000 after buying an additional 276,436 shares during the period. Finally, Spark Investment Management LLC increased its stake in shares of Genesis Healthcare by 18.9% in the 1st quarter. Spark Investment Management LLC now owns 83,000 shares of the company’s stock valued at $119,000 after buying an additional 13,200 shares during the period. Hedge funds and other institutional investors own 20.78% of the company’s stock.

GEN traded up $0.02 during trading on Friday, hitting $1.28. The company’s stock had a trading volume of 156,620 shares, compared to its average volume of 192,144. The firm’s 50 day moving average price is $1.09 and its two-hundred day moving average price is $1.24. Genesis Healthcare has a 12 month low of $0.92 and a 12 month high of $1.74. The stock has a market capitalization of $207.62 million, a price-to-earnings ratio of -0.83 and a beta of 0.94.

Genesis Healthcare (NYSE:GEN) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.13) by $0.08. The business had revenue of $1.15 billion during the quarter, compared to the consensus estimate of $1.15 billion. During the same quarter in the previous year, the firm posted ($0.39) EPS. As a group, analysts predict that Genesis Healthcare will post -0.46 earnings per share for the current year.

About Genesis Healthcare

Genesis Healthcare, Inc, together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy.

Featured Article: Does the Dogs of the Dow strategy work?

Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.